|
Collaborators
MaxThera’s product development strategy is to partner antibacterial product programs with biopharmaceutical and pharmaceutical companies having the resources and expertise to develop and commercialize products for large markets. The Company will opportunistically develop products internally that can address the unmet medical need in smaller niche markets, where highly focused clinical development and marketing efforts will be possible.
|
